Allogeneic T Cells That Express an Anti-CD19 Chimeric Antigen Receptor
Induce Remissions of B-Cell Malignancies That Progress After Allogeneic
Hematopoietic Stem-Cell Transplantation Without Causing Graft-Versus-Host
Disease
Jennifer N. Brudno, Robert P.T. Somerville, Victoria Shi, Jeremy J. Rose,
David C. Halverson, Daniel H. Fowler, Juan C. Gea-Banacloche, Steven Z.
Pavletic, Dennis D. Hickstein, Tangying L. Lu, Steven A. Feldman, Alexander
T. Iwamoto, Roger Kurlander, Irina Maric, Andre Goy, Brenna G. Hansen,
Jennifer S. Wilder, Bazetta Blacklock-Schuver, Frances T. Hakim, Steven A.
Rosenberg, Ronald E. Gress and James N. Kochenderfer⇑